LINC00513

Across TCGA pan-cancer cohorts, LINC00513 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC00513 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC00513 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00513 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUSC show a favorable association.

UVM, LIHC, and ACC are the cancer types where LINC00513 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.421	0.789	<.001	125	view →
LIHC	DFS	Tertile	All	0.436	0.642	<.001	94	view →
ACC	DFS	Tertile	All	0.261	0.705	<.001	65	view →
KICH	OS	Median	III,IV	0.468	1.000	.001	61	view →
BRCA	OS	Median	All	0.945	0.902	.002	31	view →
KIRC	DFS	Quartile	II,III,IV	0.531	0.843	.006	28	view →
BLCA	DFS	Quartile	All	0.400	0.698	.001	24	view →
LUSC	OS	Tertile	III,IV	0.607	0.271	.003	23	view →
COAD	OS	Quartile	All	0.685	0.488	.004	21	view →
MESO	OS	Median	All	0.309	0.661	.012	13	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	12	view →
SKCM	DFS	Tertile	III,IV	0.388	0.168	.024	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LINC00513–UVM (DFS)

Open the UVM breakdown →